CompletedNot Applicable

Comparison Of The Efficiencies Of Peloid and Paraffine Treatments In Patients With Hallux Rigidus

Turkey (Türkiye)80 participantsStarted 2019-05-08

Plain-language summary

In the study, the effects of peloid and paraffin treatments applied to symptomatic hallux rigidus patients on pain, functional status, quality of life and joint range of motion were evaluated and their effectiveness was compared.

Who can participate

Age range35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pain-limitation in the 1st MTF joint for three months or longer, * Being over 35 years old, * 3 or more severe pain according to VAS, * Localized tenderness over the 1st MTF on palpation. Exclusion Criteria: * Having neuropathic or radicular pain, * History of acute trauma, * Previous surgical intervention on the foot or non-operative treatment within 6 months (corticosteroid injection, physical therapy applications, shoe modifications, etc.), * Having rheumatological diseases such as rheumatoid arthritis, psoriatic arthritis, gout, * Having a malignancy, * Having a progressive neurological disease that causes sensory defects, * Being allergic to peloid therapy, * Being pregnant * Having a communication problem.

What they're measuring

Descriptive Characteristics of the Patients

Timeframe: Just before the treatment, both groups will be asked in the form of a short questionnaire.

Evaluation of Pain Severity

Timeframe: Patients were evaluated just before treatment. (1st measurement)

Evaluation of Functionality and Quality of Life

Timeframe: Patients were evaluated just before treatment. (1st measurement)

Evaluation of Quality of Life

Timeframe: Patients were evaluated just before treatment. (1st measurement)

Joint Range of Motion Measurement

Timeframe: Patients were evaluated just before treatment. (1st measurement)

Evaluation of Pain Severity

Timeframe: Patients were evaluated immediately after treatment. (2nd measurement)

Evaluation of Functionality and Quality of Life

Timeframe: Patients were evaluated immediately after treatment. (2nd measurement)

Trial details

NCT IDNCT05641038

SponsorKonya Meram State Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-06-22

View on ClinicalTrials.gov More Hallux Rigidus trials

Who can participate

Age range35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Descriptive Characteristics of the Patients

Timeframe: Just before the treatment, both groups will be asked in the form of a short questionnaire.

Evaluation of Pain Severity

Timeframe: Patients were evaluated just before treatment. (1st measurement)

Evaluation of Functionality and Quality of Life

Timeframe: Patients were evaluated just before treatment. (1st measurement)

Evaluation of Quality of Life

Timeframe: Patients were evaluated just before treatment. (1st measurement)

Joint Range of Motion Measurement

Timeframe: Patients were evaluated just before treatment. (1st measurement)

Evaluation of Pain Severity

Timeframe: Patients were evaluated immediately after treatment. (2nd measurement)

Evaluation of Functionality and Quality of Life

Timeframe: Patients were evaluated immediately after treatment. (2nd measurement)